Benign Prostate Hyperplasia (BPH) Treatment Market is expected to Grow at 8.75% through 2030F
Increasing
prevalence of benign prostate hyperplasia and product launches along with
government approvals is expected to drive the growth of Global of Benign
Prostate Hyperplasia Treatment Market during the forecast period.
According to TechSci Research report, “Benign
Prostate Hyperplasia (BPH) Treatment
Market - Global Industry Size, Share, Trends, Competition, Opportunity,
and Forecast, 2020-2030,” Global
Benign Prostate Hyperplasia (BPH) Treatment Market was valued at USD 1.53 billion
in 2024 and is expected to reach USD 2.51 billion by 2030 with a CAGR of 8.75%
during the forecast period.
BPH Treatment incorporates minimally invasive techniques. As the prostate
enlarges, it presses against the urethra. So, the bladder wall becomes thicker
and weak, ultimately losing the ability to release, leading to urine retention.
According to the name, BPH is benign and non-cancerous. However, aging and
family history increase a man’s risk of suffering from BPH.
However, stringent regulatory scenario related to the lack of awareness
regarding various urological diseases is likely to slow down the market growth
in the coming years. Also, lack of skilled medical professionals to conduct
minimally invasive surgeries pertaining to BPH Treatment especially in the
emerging countries can further slowdown the market growth.
Browse over XX market data Figures spread through XX Pages
and an in-depth TOC on "Global Benign Prostate
Hyperplasia (BPH) Treatment Market"
Global BPH Treatment Market can be segmented into drug treatment, surgical
treatment, end user, region, and company.
Based on the end user the market can be segmented into hospitals &
clinics, ambulatory surgical centers, and others. The hospitals and clinics
segment holds a dominant position in the global benign prostatic hyperplasia
(BPH) treatment market and is expected to maintain this lead in the forecast
period. This dominance is largely attributed to the continuous advancements in
healthcare infrastructure, including the availability of skilled urologists,
advanced diagnostic tools, and state-of-the-art treatment technologies such as
laser therapies and robotic-assisted procedures. Government initiatives and
favorable healthcare policies in many countries have further enhanced access to
BPH treatments by promoting insurance coverage and public health programs,
particularly in urban areas. Hospitals
and clinics are also more convenient and reliable for patients compared to
ambulatory surgical centers, as they offer comprehensive care under one roof —
from diagnosis to post-treatment monitoring. This integrated approach ensures
better outcomes and greater patient satisfaction. Also, hospitals are better
equipped to handle complex or high-risk cases, which may not be suitable for
outpatient facilities. As awareness about BPH and the importance of early
treatment continues to grow, more patients are seeking care in hospitals and
clinics, contributing to the segment’s sustained growth. Therefore, the
hospital and clinics segment is playing a crucial role in driving the overall
expansion of the global BPH treatment market
Based
on region, Asia-Pacific is the fastest-growing region in the global benign
prostatic hyperplasia (BPH) treatment market due to a combination of
demographic, economic, and healthcare-related factors. The region is witnessing
a rapid increase in its aging population, especially in countries like China,
Japan, and India, where the prevalence of BPH is rising significantly. The
increasing awareness about men’s health issues and improved health-seeking
behavior are leading to higher diagnosis and treatment rates. The expansion of
healthcare infrastructure and growing investment from both public and private
sectors are enhancing access to advanced medical technologies. Governments
across the region are also implementing initiatives to improve urological care
and increase affordability through healthcare insurance and reimbursement
programs. The entry of international and regional players offering
cost-effective treatment options is making BPH therapies more accessible. These
combined factors, along with rising disposable incomes and urbanization, are
propelling the Asia-Pacific region to emerge as the fastest-growing market for
BPH treatment.
The leading companies operating in the Global BPH Treatment Market are:
·
Boston
Scientific Corporation
·
Coloplast
Corporation
·
Teleflex
Incorporated
·
Olympus
Corporation
·
Glaxo Smith
Kline PLC
·
Eli Lily
·
Abbott
Laboratories
·
Medifocus Inc.
·
Urologix, LLC
·
Pfizer Inc.
Download Free Sample Report
Customers can also request for 10%
free customization on this report.
“The prevalence of the BPH is rising, which is encouraging the use of
cutting-edge therapies including laser therapy, prostatic stenting, and UroLift
therapy and propelling the growth of the sector in the area. The advancement of
the players in the region over the coming few years will also be supported by
attractive reimbursement rules and an increase in the number of qualified
surgeons. There are a number of device and pharmaceutical businesses in
the area, and they are all keenly interested in undertaking R&D operations
and developing new products to improve the standard of care. Furthermore, laser
therapy is widely used due to the availability of cutting-edge medical
infrastructure. Modern laser equipment is available in many clinics and urology
centres to treat BPH, which advances the area.”, said Mr. Karan Chechi,
Research Director with TechSci Research, a research based global management
consulting firm.
“BPH Treatment Market - Global Industry Size, Share, Trends, Competition,
Opportunity, and Forecast, Segmented By Drug Treatment (Alpha Blockers, 5-Alpha
Reductase Inhibitors, and phosphodiesterase-5 inhibitors), By Surgical
Treatment (Transurethral resection of the prostate (TURP), Prostatic Urethral
Lift (PUL), Prostatectomy, Laser Surgery, Transurethral Microwave Technique
(TUMT), Transurethral Needle Ablation of the Prostate (TUNA), and Others), By
End User (Hospitals & Clinics, , Ambulatory
Surgical Centers, and Others), By Region & Competition, 2020-2030F,” has
evaluated the future growth potential of Global BPH Treatment Market and
provides statistics & information on market size, structure, and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global BPH Treatment Market.
Contact
TechSci Research LLC
420 Lexington Avenue, Suite
300,
New York, United States-
10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com